Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: A population-based study
- 1 February 2007
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 43 (3) , 472-475
- https://doi.org/10.1016/j.ejca.2006.11.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Interleukin-10 and the immune response against cancer: a counterpointJournal of Leukocyte Biology, 2005
- The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzleCytokine & Growth Factor Reviews, 2003
- Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients*Critical Care Medicine, 2003
- The dual role of IL-10Trends in Immunology, 2003
- Inflammation and cancerNature, 2002
- High risk genes predisposing to prostate cancer development—do they exist?Prostate Cancer and Prostatic Diseases, 2000
- Analysis of type T1 and T2 cytokines in patients with prostate cancerThe Prostate, 2000
- Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfaHepatology, 1999
- Dietary Fat and Prostate Cancer: Current StatusJNCI Journal of the National Cancer Institute, 1999
- Haplotype associated with low interleukin-10 production in patients with severe asthmaThe Lancet, 1998